A Modern Approach to the Correction of Lipid Metabolism in Kidney Disease

Simple item page
dc.creatorShuxratovna, Khojiyeva Nozima
dc.date2022-10-13
dc.date.accessioned2023-08-21T13:12:46Z
dc.date.available2023-08-21T13:12:46Z
dc.descriptionChronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid modifying drugs — statins, fibrates, nicotinic acid was proposed.en-US
dc.formatapplication/pdf
dc.identifierhttps://procedia.online/index.php/engineering/article/view/198
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/23789
dc.languageeng
dc.publisherPROCEDIA PUBLISH GROUPen-US
dc.relationhttps://procedia.online/index.php/engineering/article/view/198/174
dc.sourceProcedia of Engineering and Medical Sciences; 2022: Proceedings of the International Congress on "Medical Improvement and Natural Sciences"; 10-16en-US
dc.source2795-563X
dc.subjectchronic kidney diseaseen-US
dc.subjectcholesterolen-US
dc.subjecttriglyceridesen-US
dc.subjectlow density lipoproteinsen-US
dc.subjecthigh density lipoproteinsen-US
dc.subjectapo AIen-US
dc.subjectapo AIIen-US
dc.subjectlipoprotein lipaseen-US
dc.subjecthepatic triglyceride lipaseen-US
dc.subjectstatinsen-US
dc.subjectfibratesen-US
dc.subjectnicotinic aciden-US
dc.titleA Modern Approach to the Correction of Lipid Metabolism in Kidney Diseaseen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files
Collections
Procedia of Engineering and Medical Sciences